Office of the Vice President for Research

Stellate DNA

Stellate DNA logo

STELLATE is the corporate entity owning intellectual property that protects the desisgn, production, distribution, and application of a unique donor catalyst that radically transforms the process of modifying genomes by CRISPR, tipping the scales from viral delivery methods to CRISPR for engineering human cells for clinical applications and beyond.


Mark Neff, CEO